Overjet Revolutionizes Dental Care with $53.2M Series C Funding
March 9, 2024, 11:04 am
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Founded date: 2018
Total raised: $130.55M
Overjet, a pioneer in dental AI, has secured a groundbreaking $53.2 million Series C financing round, marking a significant milestone in the realm of artificial intelligence for dentistry. Led by March Capital and supported by prominent investors like General Catalyst and the American Dental Association, this investment propels Overjet's total funding to approximately $133 million and elevates the company's valuation to a staggering $550 million.
Founded by experts from MIT and Harvard University, Overjet stands at the forefront of dental AI innovation, offering a revolutionary platform that empowers dental professionals to deliver superior patient care. With FDA-cleared technology that sets a new standard for oral health decision-making, Overjet enables dentists to accurately detect pathologies and educate patients with unparalleled precision and confidence.
The Series C funding will fuel Overjet's mission to prioritize patient-centric dentistry, equipping dental practitioners with cutting-edge AI tools to enhance operational efficiency and provide exceptional care. By leveraging advanced technology, Overjet has redefined the landscape of disease diagnosis in X-rays, patient education, and dental insurance claim review, setting a new benchmark in the industry.
Through strategic partnerships with dental support organizations (DSOs) and major insurers covering millions of members, Overjet has established itself as a vital resource for clinicians, administrators, and insurers alike. By training its AI on extensive case data and collaborating with top clinical specialists, Overjet ensures unparalleled accuracy in disease detection and treatment recommendations, empowering professionals to make informed decisions.
With a focus on augmenting human judgment rather than replacing it, Overjet's AI capabilities serve as a catalyst for streamlining processes, reducing uncertainty, and enhancing patient outcomes across the dental care ecosystem. By fostering seamless communication between providers, payers, and patients, Overjet aims to establish a unified standard that revolutionizes the dental industry and prioritizes patient well-being.
The addition of key executive leaders, such as Mike Lemire, Mario Paganini, and Matthew Ewing, further strengthens Overjet's position as a leader in dental AI innovation. With a commitment to continuous growth and innovation, Overjet is poised to shape the future of dentistry by making AI-driven care ubiquitous and transformative.
In the words of Overjet's CEO, Wardah Inam, "Our platform empowers dental organizations to make precise clinical decisions, enhance patient communication, and reduce administrative overhead. This funding will accelerate our mission to improve patient outcomes and make dental AI a cornerstone of modern dentistry."
As the industry continues to embrace the potential of AI in revolutionizing patient care, Overjet's groundbreaking advancements and commitment to excellence position it as a trailblazer in reshaping the future of dental healthcare.
Founded by experts from MIT and Harvard University, Overjet stands at the forefront of dental AI innovation, offering a revolutionary platform that empowers dental professionals to deliver superior patient care. With FDA-cleared technology that sets a new standard for oral health decision-making, Overjet enables dentists to accurately detect pathologies and educate patients with unparalleled precision and confidence.
The Series C funding will fuel Overjet's mission to prioritize patient-centric dentistry, equipping dental practitioners with cutting-edge AI tools to enhance operational efficiency and provide exceptional care. By leveraging advanced technology, Overjet has redefined the landscape of disease diagnosis in X-rays, patient education, and dental insurance claim review, setting a new benchmark in the industry.
Through strategic partnerships with dental support organizations (DSOs) and major insurers covering millions of members, Overjet has established itself as a vital resource for clinicians, administrators, and insurers alike. By training its AI on extensive case data and collaborating with top clinical specialists, Overjet ensures unparalleled accuracy in disease detection and treatment recommendations, empowering professionals to make informed decisions.
With a focus on augmenting human judgment rather than replacing it, Overjet's AI capabilities serve as a catalyst for streamlining processes, reducing uncertainty, and enhancing patient outcomes across the dental care ecosystem. By fostering seamless communication between providers, payers, and patients, Overjet aims to establish a unified standard that revolutionizes the dental industry and prioritizes patient well-being.
The addition of key executive leaders, such as Mike Lemire, Mario Paganini, and Matthew Ewing, further strengthens Overjet's position as a leader in dental AI innovation. With a commitment to continuous growth and innovation, Overjet is poised to shape the future of dentistry by making AI-driven care ubiquitous and transformative.
In the words of Overjet's CEO, Wardah Inam, "Our platform empowers dental organizations to make precise clinical decisions, enhance patient communication, and reduce administrative overhead. This funding will accelerate our mission to improve patient outcomes and make dental AI a cornerstone of modern dentistry."
As the industry continues to embrace the potential of AI in revolutionizing patient care, Overjet's groundbreaking advancements and commitment to excellence position it as a trailblazer in reshaping the future of dental healthcare.